{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:22:53Z","timestamp":1759483373239},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/ki.2009.204","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T12:49:20Z","timestamp":1244033360000},"page":"487-491","source":"Crossref","is-referenced-by-count":35,"title":["Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?"],"prefix":"10.1016","volume":"76","author":[{"given":"Alain Y.","family":"Meyrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.204_bb0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D'Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.204_bb0015","first-page":"439","article-title":"Minimal changes and focal-segmental glomerulosclerosis","volume":"1","author":"Meyrier","year":"2005"},{"key":"10.1038\/ki.2009.204_bb0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1523-1755.2000.00213.x","article-title":"Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation","volume":"58","author":"Shankland","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.204_bb0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2215\/CJN.04121206","article-title":"A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases","volume":"2","author":"Barisoni","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0035","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants","volume":"8","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0040","series-title":"Cochrane Database Syst Rev","article-title":"Immunosuppressive treatment for focal segmental glomerulosclerosis in adults","author":"Braun","year":"2008"},{"key":"10.1038\/ki.2009.204_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14656560902754029","article-title":"An update on the treatment options for focal segmental glomerulosclerosis","volume":"10","author":"Meyrier","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1038\/ki.2009.204_bb0050","series-title":"Evidence-Based Nephrology","first-page":"149","article-title":"Management of idiopathic nephrotic syndrome in adults: Minimal change disease and focal segmental glomerulosclerosis","author":"Meyrier","year":"2009"},{"key":"10.1038\/ki.2009.204_bb0055","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases. An update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthr and Rheum"},{"key":"10.1038\/ki.2009.204_bb0060","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effect of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.204_bb0065","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMcibr0806881","article-title":"Proteinuria and autoimmunity-An overstated relationship?","volume":"359","author":"Mathieson","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1038\/ki.2009.204_bb0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T cell function","volume":"ii","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"10.1038\/ki.2009.204_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/4.11.923","article-title":"Treatment of glomerular disease with cyclosporine A","volume":"4","author":"Meyrier","year":"1989","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 6","key":"10.1038\/ki.2009.204_bb0080","first-page":"vi79","article-title":"Treatment of idiopathic nephrosis by immunophilin modulation","volume":"18","author":"Meyrier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.204_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3181\/00379727-71-17257","article-title":"Effect of febrile plasma, typhoid vaccine and nitrogen mustard on renal manifestations of human glomerulonephritis","volume":"71","author":"Chasis","year":"1949","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1038\/ki.2009.204_bb0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","article-title":"ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses","volume":"19","author":"Berg","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.204_bb0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","article-title":"A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome","volume":"21","author":"Araya","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2009.204_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00007890-199602150-00009","article-title":"Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerulosclerosis","volume":"61","author":"Sharma","year":"1996","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.204_bb0105","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1097\/00007890-199612270-00041","article-title":"Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP","volume":"62","author":"Sharma","year":"1996","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.204_bb0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.trsl.2008.04.001","article-title":"Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity","volume":"151","author":"Savin","year":"2008","journal-title":"Transl Res"},{"key":"10.1038\/ki.2009.204_bb0115","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1523-1755.2004.00563.x","article-title":"Glomerular tip lesion: a distinct entity within the minimal change disease\/focal segmental glomerulosclerosis spectrum","volume":"65","author":"Stokes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.204_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ni0109-3","article-title":"Signaling to gene expression: calcium, calcineurin and NFAT","volume":"10","author":"Rao","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2009.204_bb0125","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfh079","article-title":"Acute rapamycine nephrotoxicity in native kidneys of patients with chronic glomerulonephritis","volume":"19","author":"Fervenza","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.204_bb0130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.204_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/gfm683","article-title":"Rituximab and nephrotic syndrome: a new therapeutic hope?","volume":"23","author":"Ahmed","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.204_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncpneph1036","article-title":"An update on the use of mycophenolate mofetil in lupus nephritis and other glomerular diseases","volume":"5","author":"Appel","year":"2009","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2009.204_bb0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/ndt\/10.7.1149","article-title":"Cyclosporin A reduces albuminuria in experimental anti-GBM nephritis independently from changes in GFR","volume":"10","author":"Schrijver","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.204_bb0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/cs0820641","article-title":"Effects of cyclosporin on glomerular barrier function in nephrotic syndrome","volume":"82","author":"Zietse","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/ki.2009.204_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1681\/ASN.V72290","article-title":"Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy","volume":"7","author":"Ambalavanan","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0160","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","article-title":"Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0165","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid-resoistant focal segmental glomerulosclerosis","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.204_bb0170","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1172\/JCI200112849","article-title":"Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin","volume":"108","author":"Schwarz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.204_bb0175","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1681\/ASN.2007010119","article-title":"Glomerular endothelial glycocalyx constitutes a barrier to protein permeability","volume":"18","author":"Singh","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0180","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporin A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.204_bb0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1681\/ASN.2007121292","article-title":"Young Investigator Award: TRP'ing into a new era for glomerular diseases","volume":"19","author":"Winn","year":"2008","journal-title":"J Am Soc Nephr"},{"key":"10.1038\/ki.2009.204_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(92)90267-F","article-title":"Recurrent focal glomerulosclerosis: natural history and response to therapy","volume":"92","author":"Artero","year":"1992","journal-title":"Am J Med"},{"key":"10.1038\/ki.2009.204_bb0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","article-title":"Transmission of glomerular permeability factor from a mother to her child","volume":"344","author":"Kemper","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.204_bb0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/ajkd.1998.v32.pm9708606","article-title":"Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis","volume":"32","author":"Feld","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.204_bb0210","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1097\/01.ASN.0000100145.27188.33","article-title":"Management of glomerular proteinuria: a commentary","volume":"14","author":"Wilmer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.204_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000441-200507000-00004","article-title":"Effects of steroids on focal segmental glomerulosclerosis in a predominantly African-American population","volume":"330","author":"Crook","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1038\/ki.2009.204_bb0220","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2009.204_bb0225","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2215\/CJN.00230107","article-title":"Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis","volume":"2","author":"Silverstein","year":"2007","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T17:36:27Z","timestamp":1633541787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815540040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0085253815540040"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.204","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}